Recent trends in mortality due to chronic obstructive pulmonary disease (COPD) in Mexico, 1980-2002

被引:6
|
作者
Guzmán, VJT [1 ]
Antuñano, FJL [1 ]
Salgado, NR [1 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest & Salud Poblac, Dept Invest & Tabaco, Cuernavaca 62508, Morelos, Mexico
关键词
mortality; COPD; Mexico; epidemiology; trends;
D O I
10.1016/j.arcmed.2004.11.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible. Changes in classification have a major impact on reported mortality rates. Methods. Between 1980 and 2002, 230,463 COPD cases were studied (age group 35-94 years); 134,579 men; 95,884 women. Results. The crude mortality rate varied from 37 (1980) to 61 per 100,000 men (2002), (increase: 65%). The crude mortality rate for females increased from 27 (1980) to 43 deaths per 100,000 women (2002), (increase: 56%). The trends of the absolute values by birth year and age groups are higher as age increases. As age of death comes down and the birth cohort increases, the absolute values decrease. The Mexican states located in the northern and central areas present a higher risk for dying. There is an increment coefficient of 93 cases per increment year in males (age group 35-74), and 61 cases per increment year in females (age group 35-74 years). For the age group 35-94 years, the annual increase for males is 288 cases. These results were statistically significant, and the regression model was validated by residual analysis. Conclusions. The oldest cohorts of the studied population showed the highest COPD mortality absolute values. The geographic risk of dying from COPD is concentrated in two regions: a) the three Mexican states of higher economic income at the northern frontier to the U.S. and b) those Mexican states surrounding the main producer of tobacco (Nayarit). (c) 2005 IMSS. Published by Elsevier Inc.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
  • [41] Epidemiology of Chronic Obstructive Pulmonary Disease (COPD)
    Viegi, G
    Scognamiglio, A
    Baldacci, S
    Pistelli, F
    Carrozzi, L
    RESPIRATION, 2001, 68 (01) : 4 - 19
  • [42] Bronchodilators in chronic obstructive pulmonary disease (COPD)
    Gillissen, A
    Buhl, R
    Rabe, KF
    Vogelmeier, C
    Welte, J
    MEDIZINISCHE KLINIK, 2005, 100 (05) : 246 - 254
  • [43] Chronic obstructive pulmonary disease (COPD) in the elderly
    Orvoen-Frija, E.
    Benoit, M.
    Catto, M.
    Chambouleyron, M.
    Duguet, A.
    Emeriau, J-P
    Ferry, M.
    Hayot, M.
    Jeandel, C.
    Morize, V.
    Nassih, K.
    Ouksel, H.
    Piette, F.
    Prefaut, C.
    Roche, N.
    de Wazieres, B.
    Zureik, M.
    REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (08) : 855 - 873
  • [44] Exercise and Chronic Obstructive Pulmonary Disease (COPD)
    Fiorentino, Giuseppe
    Esquinas, Antonio M.
    Annunziata, Anna
    PHYSICAL EXERCISE FOR HUMAN HEALTH, 2020, 1228 : 355 - 368
  • [45] INDACATEROL FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Cazzola, M.
    Proietto, A.
    Matera, M. G.
    DRUGS OF TODAY, 2010, 46 (03) : 139 - 150
  • [46] Chronic obstructive pulmonary disease (COPD) - Introduction
    Zabel, P.
    INTERNIST, 2006, 47 (09): : 883 - 884
  • [47] Pathomechanisms in chronic obstructive pulmonary disease (COPD)
    Glaab, Thomas
    Hohlfeld, Jens M.
    Joerres, Rudolf A.
    Krug, Norbert
    Welte, Tobias
    MEDIZINISCHE KLINIK, 2006, 101 (12) : 951 - 956
  • [48] Chronic obstructive pulmonary disease (COPD) and sleep
    Galetke, Wolfgang
    SOMNOLOGIE, 2020, 24 (01): : 5 - 10
  • [49] The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Park, Hye Yun
    Man, S. F. Paul
    Tashkin, Donald
    Wise, Robert A.
    Connett, John E.
    Anthonisen, Nicholas A.
    Sin, Don D.
    PLOS ONE, 2013, 8 (04):
  • [50] Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking
    Pride, NB
    Soriano, JB
    CURRENT OPINION IN PULMONARY MEDICINE, 2002, 8 (02) : 95 - 101